InsidersTradesSigma
Sunshine Biopharma, Inc: management transactions · United States · SEC (Form 4)
SEC:sunshine-biopharma-inc-6e9898US·SEC (Form 4)Mcap 4M€Healthcare
Browse the full insider trade history of Sunshine Biopharma, Inc, a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, Sunshine Biopharma, Inc has recorded 2 insider filings. Market capitalisation: €4.4m. The latest transaction was disclosed on 6 June 2022 — Acquisition. Among the most active insiders: Sebaaly Camille. All data is free.
2
Insider Decl.
0
Thresholds
€28,369
1 ops.
Buy Volume
€87,098
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.89 €
Analyst consensus
1 analysts5.60 €Target 5.60 €(+531%)5.60 €
Income statement
Revenue36.3 M€
Gross profit12.3 M€34% margin
Net income−6.0 M€-17.0% margin
Valuation
P/Book0.2x
Balance sheet & cash
Market cap4.4 M€
Total debt812 k€
Free Cash Flow−6.2 M€
Debt / Equity3%
Profitability & ownership
ROE-27.3%
ROA-10.0%
% insiders2.0%
% institutions5.3%
Last declaration on 6 June 2022
Declarations2 total
Executives▲Purchase44SEC
€28,36925,000 shares@ €1.13480.65% mcap100.0% of flow
Common Stock
SEC:0001683168-22-004178:0·
Ideal exit: 28 Feb 2023 (T+270)
Executives●Disposition◆Signal · 45SEC
€87,098990,000 shares@ €0.0882.00% mcap100.0% of flow
Series B Preferred Stock
SEC:0001683168-22-001185:0·
2 of 2 declarations